{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:02:39Z","timestamp":1790240559560,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cellimm.2019.103958","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T02:06:14Z","timestamp":1563933974000},"page":"103958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"344","author":[{"given":"Xiaole","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangfan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2019.103958_b0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.103958_b0010","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0903474106","article-title":"The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity","author":"Stanietsky","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellimm.2019.103958_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.103958_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005761","article-title":"CD4+T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART","volume":"12","author":"Fromentin","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2019.103958_b0025","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.103958_b0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI80445","article-title":"TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients","author":"Chauvin","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2019.103958_b0035","first-page":"4921","article-title":"Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells","volume":"183","author":"Carlsten","year":"2009","journal-title":"J. Immunol. Am. Assoc. Immunol."},{"key":"10.1016\/j.cellimm.2019.103958_b0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.103958_b0045","first-page":"3673","article-title":"The CD226\/CD155 interaction regulates the proinflammatory (Th1\/Th17)\/anti-inflammatory (Th2) balance in humans","volume":"191","author":"Lozano","year":"2013","journal-title":"J. Immunol. NIH Public Access"},{"key":"10.1016\/j.cellimm.2019.103958_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1074-7613(00)70060-4","article-title":"DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes","author":"Shibuya","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2019.103958_b0055","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20081752","article-title":"DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors","author":"Gilfillan","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2019.103958_b0060","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201041136","article-title":"Vstm3 is a member of the CD28 family and an important modulator of T-cell function","author":"Levin","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2019.103958_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2019.103958_b0070","article-title":"Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells","author":"Liu","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellimm.2019.103958_b0075","article-title":"T-cell immunoglobulin and ITIM domain (TIGIT) receptor\/poliovirus receptor (PVR) ligand engagement suppresses interferon-\u03b3 production of natural killer cells via \u03b2-arrestin 2-mediated negative signaling","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2019.103958_b0080","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1003081","article-title":"Cutting edge: TIGIT has T cell-intrinsic inhibitory functions","author":"Joller","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2019.103958_b0085","doi-asserted-by":"crossref","DOI":"10.1172\/JCI81187","article-title":"TIGIT predominantly regulates the immune response via regulatory T cells","author":"Kurtulus","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2019.103958_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","author":"Chew","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2019.103958_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2016.09.010","article-title":"Adult acute lymphoblastic leukemia","author":"Paul","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cellimm.2019.103958_b0100","first-page":"29","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellimm.2019.103958_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2015.12.007","article-title":"Clinical updates in adult acute lymphoblastic leukemia","author":"Ustwani Al","year":"2016","journal-title":"Crit. Rev. Oncol."},{"key":"10.1016\/j.cellimm.2019.103958_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29383","article-title":"New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia","author":"Jabbour","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cellimm.2019.103958_b0115","article-title":"T-cell immunoglobulin and ITIM domain (TIGIT) associates with CD8+ T-cell exhaustion and poor clinical outcome in AML patients","author":"Kong","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2019.103958_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-018-0288-y","article-title":"Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option","author":"Stamm","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2019.103958_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT)","author":"Yasuma","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2019.103958_b0130","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-17-2337","article-title":"T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling","author":"Josefsson","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2019.103958_b0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2019.103958_b0140","doi-asserted-by":"crossref","DOI":"10.1089\/15258160260194749","article-title":"A review of the Wilms\u2019 Tumor 1 gene (WT1) and its role in hematopoiesis and leukemia","author":"Algar","year":"2002","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.cellimm.2019.103958_b0145","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1700407","article-title":"Functional anti-TIGIT antibodies regulate development of autoimmunity and antitumor immunity","author":"Dixon","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2019.103958_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2016.10.002","article-title":"TIGIT: a key inhibitor of the cancer immunity cycle","author":"Manieri","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2019.103958_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8+T cell effector function","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellimm.2019.103958_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2015.08.003","article-title":"TIGIT negatively regulates inflammation by altering macrophage phenotype","author":"Chen","year":"2016","journal-title":"Immunobiology"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874919301790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874919301790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:59:07Z","timestamp":1757804347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874919301790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":32,"alternative-id":["S0008874919301790"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2019.103958","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2019.103958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103958"}}